Sana Biotechnology, Inc. (NASDAQ: SANA) reported Q2 EPS of ($0.39), $0.19 worse than the analyst estimate of ($0.20).

For earnings history and earnings-related data on Sana Biotechnology, Inc. (SANA) click here.